Lavior Pharma Wins Award for Transforming Wound Care Through Bio-Engineered Botanicals
MIAMI, May 28, 2025 /PRNewswire/ -- Lavior Pharma is proud to announce it has received the Small Business Spotlight Award at the 2025 Business At Its Best Awards, hosted by the Florida SBDC at FIU Business. The award recognizes Lavior's clinically proven, botanical bio-engineered wound care and skincare innovations that are transforming lives in the U.S. and worldwide.
Co-founders Gilad and Anabelle Savion were recognized for pioneering clinically proven therapies that combine botanical science with advanced medical research. Proudly manufactured in the USA, Lavior's products are designed to accelerate healing for individuals with diabetes and chronic skin conditions.
"This award is more than a milestone — it's a powerful validation of our mission to merge the healing power of nature with cutting-edge clinical research," said Gilad Savion, CEO of Lavior Pharma.
At the core of the company's innovation is Inula viscosa AGS-RIED, a proprietary, bio-engineered botanical developed over seven years. This patented extract supports the immune system and addresses the inflammation, proliferation, and remodeling stages of healing.
"It's the only natural pharmaceutical clinically proven in clinical trials to move chronic wounds from the inflammatory stage to healing in just three weeks," said Gilad.
Lavior has emerged as a leader in wound care innovation. Its science-backed products help prevent amputations and improve quality of life.
"At Lavior, we aim to make a positive impact and improve lives," said Anabelle Savion, COO. "This recognition reflects our commitment to quality, innovation, and the people we serve."
"It honors our past, the dedication of our team, and the vision we carry into the future — with a commitment to accessibility, affordability, and U.S. manufacturing," she added.
The Business At Its Best Awards brought together industry and government leaders, including Paul Fitzpatrick, Associate Administrator at the U.S. Small Business Administration (SBA), who emphasized the importance of investing in American manufacturing.
"While each award category is different, a common thread is that each honoree has demonstrated success and inspired others," said Brian Van Hook, Regional Director of the Florida SBDC at FIU.
This recognition comes at a pivotal time as Lavior prepares for a national retail launch with Target, expands its product line, and grows its international reach.
"Global expansion is a top priority," Gilad said. "We're building strategic partnerships, expanding education, and planning joint ventures to ensure our therapies are both accessible and affordable."
Lavior extends its gratitude to the Florida SBDC at FIU, and to the community of patients, customers, clinicians, and supporters behind its mission.
"We're building more than a company — we're building a legacy of healing," Gilad concluded.
Media Contact:
Anabelle Savion
(305) 627-3680
395815@email4pr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lavior-pharma-wins-award-for-transforming-wound-care-through-bio-engineered-botanicals-302467215.html
SOURCE Lavior